Collagen, Type IV, alpha 6 (COL4a6) Peptide
COL4a6
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all COL4a6 products
- COL4a6 (Collagen, Type IV, alpha 6 (COL4a6))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GIKGKSGLPG APGFPGISGH PGKKGTRGKK GPPGSIVKKG LPGLKGLPGN
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of COL4 A6 antibody,
Alternative Names: COL4A6 control peptide, COL4A6 antibody Blocking Peptide, Anti-COL4A6 Blocking Peptide, collagen, type IV, alpha 6 Blocking Peptide, MGC88184 Blocking Peptide, COL4A6, COLA6-4, COLA6 4, COLA6-4 Blocking Peptide, COLA6 4 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- COL4a6 (Collagen, Type IV, alpha 6 (COL4a6))
- Background
- This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Two splice variants have been identified for this gene.
- Molecular Weight
- 161 kDa
-
You are here:
